Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Inflation Reduction Act
BioCentury In Depth
The Inflation Reduction Act
The Inflation Reduction Act, signed into law on Aug. 16, 2022, set in motion broad-based drug price regulation as well as changes to the Medicare program that are fundamentally reshaping the drug development ecosystem. A comprehensive knowledge of the law has become essential for drug development decision-making, including for investments and pipeline prioritization.
BioCentury is providing deep analysis of the law, exploring its impacts and explaining how the federal government is implementing it. This analysis is complemented by perspectives from business and policy leaders on options for medical product developers to navigate the new landscape, and reporting on the biopharmaceutical industry’s attempts to modify or derail the IRA through litigation and legislation.
Sign up now (free) for access to the featured stories below, and put BioCentury to work for you.
Sign Up
Do you already have an account? Log in.
Featured Analysis
Complimentary access with registration
More Inflation Reduction Act Coverage from BioCentury
Available to BioCentury Subscribers Only